DOP2014000171A - Sistema para la administración de fármacos - Google Patents

Sistema para la administración de fármacos

Info

Publication number
DOP2014000171A
DOP2014000171A DO2014000171A DO2014000171A DOP2014000171A DO P2014000171 A DOP2014000171 A DO P2014000171A DO 2014000171 A DO2014000171 A DO 2014000171A DO 2014000171 A DO2014000171 A DO 2014000171A DO P2014000171 A DOP2014000171 A DO P2014000171A
Authority
DO
Dominican Republic
Prior art keywords
membrane
core
drug administration
administration system
intermediate layer
Prior art date
Application number
DO2014000171A
Other languages
English (en)
Inventor
Harri Jukarainen
Heikki Lyytikäinen
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47666152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2014000171(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of DOP2014000171A publication Critical patent/DOP2014000171A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Un sistema para la administración de fármacos para la liberación controlada de sustancias terapéuticamente activas a una tasa de liberación predeterminada, esencialmente constante durante un período de tiempo prolongado. El sistema de administración comprende al menos un núcleo que comprende dicha(s) sustancia(s) terapéuticamente activa(s), al menos una membrana que encierra el núcleo y una capa intermedia de un material sustancialmente inerte, en donde la capa intermedia se aplica entre el núcleo y la membrana o entre las dos capas de membrana.
DO2014000171A 2012-01-23 2014-07-23 Sistema para la administración de fármacos DOP2014000171A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20125069 2012-01-23

Publications (1)

Publication Number Publication Date
DOP2014000171A true DOP2014000171A (es) 2014-08-15

Family

ID=47666152

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2014000171A DOP2014000171A (es) 2012-01-23 2014-07-23 Sistema para la administración de fármacos

Country Status (38)

Country Link
US (1) US10500381B2 (es)
EP (1) EP2806893B1 (es)
JP (1) JP6236401B2 (es)
KR (1) KR102004014B1 (es)
CN (1) CN104144702B (es)
AR (1) AR089765A1 (es)
AU (1) AU2013213514B2 (es)
BR (1) BR112014017834B1 (es)
CA (1) CA2861947A1 (es)
CL (1) CL2014001935A1 (es)
CO (1) CO7020911A2 (es)
CR (1) CR20140358A (es)
CU (1) CU24431B1 (es)
CY (1) CY1120773T1 (es)
DK (1) DK2806893T3 (es)
DO (1) DOP2014000171A (es)
EA (1) EA032208B1 (es)
EC (1) ECSP14010605A (es)
ES (1) ES2691635T3 (es)
HR (1) HRP20181707T1 (es)
IL (1) IL233599B (es)
LT (1) LT2806893T (es)
MX (1) MX355961B (es)
MY (1) MY172812A (es)
NZ (1) NZ627461A (es)
PE (1) PE20141818A1 (es)
PH (1) PH12014501654B1 (es)
PL (1) PL2806893T3 (es)
PT (1) PT2806893T (es)
RS (1) RS57911B1 (es)
SG (1) SG11201404032SA (es)
SI (1) SI2806893T1 (es)
TR (1) TR201815247T4 (es)
TW (1) TWI626951B (es)
UA (1) UA116197C2 (es)
UY (1) UY34583A (es)
WO (1) WO2013110856A1 (es)
ZA (1) ZA201406206B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
PL2982352T3 (pl) * 2014-06-28 2019-01-31 Laboratorios Andrómaco S.A. Krążek szyjki macicy zawierający progesteron do długotrwałego, przedłużonego i ciągłego uwalniania, stosowany w celu zapobiegania przed przedwczesnym porodem
MX2018007674A (es) * 2015-12-21 2018-09-12 Bayer Oy Un metodo para la fabricacion de un anillo vaginal.
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
JP7242648B2 (ja) * 2017-09-27 2023-03-20 バイエル・オサケユキテュア エラストマーマトリックスからの治療活性剤の放出を変更するための方法
CN109954198B (zh) * 2017-12-25 2021-10-12 先健科技(深圳)有限公司 药物球囊及其制备方法
CA3130212A1 (en) * 2019-02-19 2020-08-27 Particle Sciences, Inc. Compartmentalized drug delivery devices

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054784T3 (es) * 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
WO2001085132A1 (en) 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
AU2002210580A1 (en) 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
HUP0401438A3 (en) 2001-08-31 2008-04-28 Schering Oy Drug delivery system
DE10209979A1 (de) 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
DE602005014962D1 (de) 2004-03-12 2009-07-30 Biodel Inc Insulinzusammensetzungen mit verbesserter wirkstoffabsorption
SI1629844T1 (sl) 2004-07-13 2007-12-31 Bayer Schering Pharma Oy Sistem podaljšanega oddajanja s kontrolirano začetno dozo
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
AU2006213439A1 (en) 2005-01-03 2006-08-17 Lupin Limited Pharmaceutical composition of acid labile substances
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US8137327B2 (en) 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
MX2009005364A (es) 2006-11-20 2009-06-05 Organon Nv Sistema de suministro de farmaco con forma helicoidal.
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI121000B (fi) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
CN103347496A (zh) * 2010-12-27 2013-10-09 道康宁公司 药物递送分散体以及由其形成的膜

Also Published As

Publication number Publication date
PH12014501654A1 (en) 2014-10-13
CN104144702A (zh) 2014-11-12
CO7020911A2 (es) 2014-08-11
PH12014501654B1 (en) 2014-10-13
BR112014017834A2 (es) 2017-06-20
EA032208B1 (ru) 2019-04-30
CY1120773T1 (el) 2019-12-11
KR20140127262A (ko) 2014-11-03
EP2806893A1 (en) 2014-12-03
UA116197C2 (uk) 2018-02-26
IL233599B (en) 2019-07-31
TWI626951B (zh) 2018-06-21
TR201815247T4 (tr) 2018-11-21
EP2806893B1 (en) 2018-07-18
MX2014008906A (es) 2014-08-26
TW201343204A (zh) 2013-11-01
NZ627461A (en) 2016-07-29
PT2806893T (pt) 2018-11-09
SG11201404032SA (en) 2014-08-28
US20140350488A1 (en) 2014-11-27
AR089765A1 (es) 2014-09-17
IL233599A0 (en) 2014-08-31
ZA201406206B (en) 2019-06-26
RS57911B1 (sr) 2019-01-31
CL2014001935A1 (es) 2015-04-10
CR20140358A (es) 2014-11-17
CU24431B1 (es) 2019-07-04
PE20141818A1 (es) 2014-12-18
WO2013110856A1 (en) 2013-08-01
ES2691635T3 (es) 2018-11-28
JP2015504083A (ja) 2015-02-05
SI2806893T1 (sl) 2019-02-28
US10500381B2 (en) 2019-12-10
MY172812A (en) 2019-12-12
HRP20181707T1 (hr) 2019-02-22
CU20140094A7 (es) 2014-11-27
EA201400834A1 (ru) 2014-12-30
JP6236401B2 (ja) 2017-11-22
LT2806893T (lt) 2018-12-10
CN104144702B (zh) 2018-03-06
KR102004014B1 (ko) 2019-07-25
AU2013213514B2 (en) 2017-07-13
CA2861947A1 (en) 2013-08-01
ECSP14010605A (es) 2015-12-31
PL2806893T3 (pl) 2019-01-31
HK1203802A1 (en) 2015-11-06
UY34583A (es) 2013-09-02
DK2806893T3 (en) 2018-11-05
BR112014017834B1 (pt) 2021-05-18
MX355961B (es) 2018-05-07
AU2013213514A1 (en) 2014-08-07
BR112014017834A8 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
DOP2014000171A (es) Sistema para la administración de fármacos
EP2589379A4 (en) TRANSDERMAL AGGREGATE FREEZING SYSTEM WITH DONEPEZIL
WO2014116650A3 (en) Transdermal drug delivery system and method
CO2019000643A2 (es) Formulaciones gastrorretentivas orales y usos de las mismas
CY1116638T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
LTPA2019508I1 (lt) Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
CL2009001556A1 (es) Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol.
SG194155A1 (en) Multilayer thin film drug delivery device and methods of making and using the same
BR112013029199A2 (pt) sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo
DK2613784T3 (da) Indretning til transdermal indgivelse af lægemiddel
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
CL2013000477A1 (es) Formulacion farmaceutica oral de liberacion inmediata que comprende nalbufina o una sal de la misma, y al menos, un soporte de granulacion hidrofilo, un aglutinante hidrofilo y un lubricante, util para el tratamiento del dolor y la dependencia a los opioides.
ES2570205T3 (es) Sistema terapéutico transdérmico con pequeña tendencia a la cristalización espontánea
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
MY166972A (en) Transdermal delivery system containing galantamine or salts thereof
CR20150363A (es) Combinación de un medicamento que comprende fenilefrina y paracetamol
PE20140675A1 (es) Comprimido farmaceutico de liberacion controlada para administracion oral
TH95747A (th) การนำส่งทางผิวหนังของเมปตาซินอล
TH153173A (th) ระบบการนำส่งยา
UA113061C2 (xx) Система доставки лікарського засобу
EA201992463A1 (ru) Система доставки лекарственного средства
TH164080A (th) รูปเเบบยาของเเข็ง
AR090022A1 (es) Sistema de administracion de medicamentos por tubo de alginato y metodo a ese efecto
ES2328653B1 (es) Combinacion de sustancias activas para el tratamiento de la diabetes.
UY30536A1 (es) Sistema de liberacion farmacéutica controlada, particularmente administracion oral de sustancias activas con solubilidades de ph, preparacion y aplicacion.